Abstract
In the present study, a series of novel Trp-Pro-Val containing peptides were prepared via solid-phase synthesis, and their structures were cyclized by a disulfide bridge, or modified by adding heterocycles of pyrazine, pyroglutamic acid, and 1,3,4-oxadiazoles to their N-terminus. These peptides were designed to antagonize gonadotropin-releasing hormone (GnRH)-receptor. Based on the detailed in vitro studies, incorporation of disulfide bond (peptide 1), the addition of pyroglutamate at the N-terminus (peptide 2), the addition of pyrazine at the N-terminus (peptide 3), and incorporation of GFRW to the N-terminus (peptide 5) were beneficial for inhibition of proliferation and induction of apoptosis in GnRH receptor-bearing cells including Hela and MCF-7 cell lines, whereas ineffective on Hep-G2 liver cancer and SW-48 colorectal adenocarcinoma cell lines devoiding of GnRH receptor. These results imply that the synthesized peptides 1, 2, 3, and 5 are GnRH antagonists and selective for GnRH receptors on the surface of tumor cells.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-021-02484-6/MediaObjects/13738_2021_2484_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-021-02484-6/MediaObjects/13738_2021_2484_Sch1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-021-02484-6/MediaObjects/13738_2021_2484_Sch2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-021-02484-6/MediaObjects/13738_2021_2484_Sch3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-021-02484-6/MediaObjects/13738_2021_2484_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-021-02484-6/MediaObjects/13738_2021_2484_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-021-02484-6/MediaObjects/13738_2021_2484_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-021-02484-6/MediaObjects/13738_2021_2484_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13738-021-02484-6/MediaObjects/13738_2021_2484_Fig6_HTML.png)
Similar content being viewed by others
References
E.J. Neer, Protein Sci. 3, 3 (1994)
H.E. Hamm, J. Biol. Chem. 273, 669 (1998)
A. Thathiah, B. De Strooper, Sci. Signal. 2, re8 (2009).
D.M. Harris, H.I. Cohn, S. Pesant, A.D. Eckhart, Clin. Sci. 115, 79 (2008)
L. Nogués, J. Palacios-García, C. Reglero, V. Rivas, M. Neves, C. Ribas, P. Penela, F. Mayor Jr, in Seminars in Cancer Biology Elsevier, 2018, p. 78
C. Liebmann, Curr. Pharm. Des. 10, 1937 (2004)
F. Schneider, W. Tomek, C. Gründker, Theriogenology 66, 691 (2006)
K. Eidne, C. Flanagan, N. Harris, R. Millar, J. Clin. Endocrinol. Metab. 64, 425 (1987)
C. Gründker, G. Emons, Front. Endocrinol. 8, 187 (2017)
C. Lambalk, F. Banga, J. Huirne, M. Toftager, A. Pinborg, R. Homburg, F. Van Der Veen, M. Van Wely, Hum. Reprod Update. 23, 560 (2017)
F.-L. Tukun, D.E. Olberg, P.J. Riss, I. Haraldsen, A. Kaass, J. Klaveness, Molecules 22, 2188 (2017)
S. Ma, S. Pradeep, A. Villar-Prados, Y. Wen, E. Bayraktar, L.S. Mangala, M.S. Kim, S.Y. Wu, W. Hu, C. Rodriguez-Aguayo, Mol. Cancer Ther. 18, 969 (2019)
C.A. Hoeger, J.E. Rivier, P.G. Theobald, J.S. Porter, Peptide intermediates for making GnRH antagonists. US19960727798727, (1996)
E. Lenci, A. Trabocchi, Chem. Soc. Rev. 49, 3262 (2020)
V. Fathi Vavsari, S. Balalaie, J. Iran. Chem. Soc. (2021) https://doi.org/10.1007/s13738-021-02312-x
M. Farhadpour, H. Hashempour, Z. Talebpour, A. Nazanin, M.S. Shushtarian, C.W. Gruber, A. Ghassempour, Anal. Biochem. 497, 83 (2016)
H. Hashempour, J. Koehbach, N.L. Daly, A. Ghassempour, C.W. Gruber, Amino Acids 44, 581 (2013)
M.A. Esmaeili, N. Abagheri-Mahabadi, H. Hashempour, M. Farhadpour, C.W. Gruber, A. Ghassempour, Fitoterapia 109, 162 (2016)
M. Góngora-Benítez, J. Tulla-Puche, F. Albericio, Chem. Rev. 114, 901 (2014)
A.R. Oyler, R.E. Naldi, J.R. Lloyd, D.A. Graden, C.J. Shaw, M.L. Cotter, J. Pharm. Sci. 80, 271 (1991)
F. Hamdan, Z. Bigdeli, S. Balalaie, N. Sewald, C. Michalek, New J. Chem. 43, 2702 (2019)
R.E. Wang, Y. Niu, H. Wu, M.N. Amin, J. Cai, Am. J. Nucl. Med. Mol. Imaging. 1, 36 (2011)
F. Hamdan, Z. Bigdeli, S.M. Asghari, A. Sadremomtaz, S. Balalaie, ChemMedChem 14, 282 (2019)
A. Corti, F. Curnis, Curr. Pharma. Biotech 12, 1128 (2011)
W. Kim, M.H. Hecht, Proc. Natl. AcadSci. U.S.A. 103, 15824 (2006)
M. Dolezal, J. Zitko, Expert Opin. Ther. Pat. 25, 33 (2015)
F. Lumachi, D.A. Santeufemia, S.M. Basso, World J. Biological Chem. 6, 231 (2015)
R. Eliasen, N.L. Daly, B.S. Wulff, T.L. Andresen, K.W. Conde-Frieboes, D.J. Craik, J. Biolog. Chem. 287, 40493 (2012)
N. Uchida, K. Ishiguro, T. Suda, Y. Horie, M. Nishimura, Yonago. Acta Medica. 53, 71 (2010)
J.R. Frost, C.C. Scully, A.K. Yudin, Nat. Chem. 8, 1105 (2016)
F. Golmohammadi, S. Balalaie, F. Hamdan, S. Maghari, New J. Chem. 42, 4344 (2018)
S. Maghari, S. Ramezanpour, F. Darvish, S. Balalaie, F. Rominger, H.R. Bijanzadeh, Tetrahedron 69, 2075 (2013)
A. Finch, K. Sedgley, S. Armstrong, C. Caunt, C. McArdle, Br. J. Pharmacol. 159, 751 (2010)
A.R. Finch, K.R. Sedgley, C.J. Caunt, C.A. McArdle, J. Endocrinol. 196, 353 (2008)
R. Eaveri, A. Ben-Yehudah, H. Lorberboum-Galski, Curr. Cancer Drug Targets. 4, 673 (2004)
D. Pati, H. Habibi, Endocrinology 136, 75 (1995)
S.E. Logue, M. Elgendy, S.J. Martin, Nat. Protoc. 4, 1383 (2009)
C.M. Henry, E. Hollville, S.J. Martin, Methods 61, 90 (2013)
Acknowledgements
S.B. thanks Alexander von Humboldt Foundation for the Linkage Research Group program.
Author information
Authors and Affiliations
Corresponding authors
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Shakeri, P., Asghari, S.M., Panahi Kokhdan, E. et al. Synthesis, molecular modeling and functional evaluation of a GnRH antagonist. J IRAN CHEM SOC 19, 2705–2717 (2022). https://doi.org/10.1007/s13738-021-02484-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-021-02484-6